IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAF5. A total of 24 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,662,400 | +100.6% | 10,000,000 | +108.3% | 0.00% | +50.0% |
| Q2 2023 | $4,815,936 | +48059.4% | 4,800,000 | +47900.0% | 0.00% | – |
| Q3 2022 | $10,000 | -23.1% | 10,000 | -21.6% | 0.00% | – |
| Q2 2022 | $13,000 | -99.9% | 12,750 | -99.9% | 0.00% | -100.0% |
| Q1 2022 | $18,457,000 | – | 16,006,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 12,388 | $12,458,000 | 0.88% |
| SHENKMAN CAPITAL MANAGEMENT INC | 13,818,000 | $13,900,000 | 0.78% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 3,500,000 | $3,510,000 | 0.62% |
| WOLVERINE ASSET MANAGEMENT LLC | 28,655,000 | $28,803,000 | 0.31% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 12,334,000 | $12,434,000 | 0.28% |
| CSS LLC/IL | 5,000,000 | $5,024,000 | 0.24% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 22,700,000 | $22,913,000 | 0.14% |
| Jefferies Group LLC | 7,347,000 | $7,413,724 | 0.06% |
| FORESIGHT CAPITAL MANAGEMENT ADVISORS, INC. | 26,000 | $26,000 | 0.04% |
| Calamos Advisors LLC | 7,500,000 | $7,542,000 | 0.03% |